公司简介

CRISPR Therapeutics is a bio-pharmaceutical company that translates CRISPR-Cas9.

主要成员

Daniel Anderson、Emmanuelle Charpentier、Shaun Foy、Rodger Novak、Craig Mello

产品/服务

• 基因合成/编辑

CRISPR/Cas9 GENE EDITING

we can harness to precisely modify, delete or correct disease-causing abnormalities at their genetic sources.

融资信息

融资轮次	融资日期	投资方	融资额度
Series A	2014-04	Versant Ventures	$25M
Series B	2015-04	New Enterprise Associate、Versant、SR One、Abingworth、Celgene、GlaxoSmithKline、Vertex Pharmaceuticals	$64M
Series B	2016-06	New Leaf 、Franklin Templeton Investments、Clough Capital Partners、Wellington Capital Management	$38M

关联公司